A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2

Virology. 1998 Jun 5;245(2):353-9. doi: 10.1006/viro.1998.9168.

Abstract

We used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L2 (L1/L2 capsids) as an antigen to produce mouse monoclonal antibodies (MAbs). Of 18 MAbs recognizing surface epitopes of L1/L2 capsids, 1 was an anti-L1 MAb and 17 were anti-L2 MAbs. Seven of 11 anti-L2 MAbs recognizing linear epitopes wer found to bind to a synthetic peptide with an HPV-16 L2 sequence of amino acids (aa) 69-81, which is within a highly conserved region among different HPVs. The synthetic peptide reacted with the human sera that had been shown to be positive for an antibody against HPV-16, -18, -58, or -6b capsids composed of L1 alone. The data suggest that the HPV-16 L2 region of aa 69-81 contains a type-common immunodeterminant exposed on the surface of HPV virions.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Viral / immunology*
  • Antibody Specificity
  • Antigens, Viral / immunology*
  • Capsid / immunology*
  • Capsid Proteins*
  • Cross Reactions
  • Humans
  • Immunodominant Epitopes / immunology*
  • Mice
  • Oncogene Proteins, Viral / immunology*
  • Papillomaviridae / immunology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Viral
  • Antigens, Viral
  • Capsid Proteins
  • Immunodominant Epitopes
  • L2 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral